Pierre Renard

6.1k total citations
160 papers, 5.1k citations indexed

About

Pierre Renard is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pierre Renard has authored 160 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Organic Chemistry, 78 papers in Molecular Biology and 28 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pierre Renard's work include Cancer therapeutics and mechanisms (26 papers), Circadian rhythm and melatonin (25 papers) and Synthesis and Biological Evaluation (24 papers). Pierre Renard is often cited by papers focused on Cancer therapeutics and mechanisms (26 papers), Circadian rhythm and melatonin (25 papers) and Synthesis and Biological Evaluation (24 papers). Pierre Renard collaborates with scholars based in France, China and Spain. Pierre Renard's co-authors include Bruno Pfeiffer, Philippe Delagrange, Béatrice Guardiola‐Lemaître, Stéphane Léonce, Elisabeth Mocaër, Daniel‐Henri Caignard, Alain St. Pierre, Jean A. Boutin, Daniel Lesieur and Mark J. Millan and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Pierre Renard

158 papers receiving 5.0k citations

Peers

Countries citing papers authored by Pierre Renard

Since Specialization

Citations

This map shows the geographic impact of Pierre Renard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Renard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Renard more than expected).

Fields of papers citing papers by Pierre Renard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Renard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Renard. The network helps show where Pierre Renard may publish in the future.

Co-authorship network of co-authors of Pierre Renard

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Renard. A scholar is included among the top collaborators of Pierre Renard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Renard. Pierre Renard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of catalytic and non‐catalytic activity inhibitors against PRC2‐EZH2 complex through multiple high‐throughput screening campaigns 2020 ·Chemical Biology & Drug Design ·Yan Zhou, Daohai Du, Jia Wang, Xiaoqing Cai, (unknown), Olivier Nosjean, Jean A. Boutin, Pierre Renard, Dehua Yang, Cheng Luo, Ming‐Wei Wang	7
2	W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway 2017 ·Acta Pharmacologica Sinica ·Ting Li, Guangyao Lin, Zhong Li, Yan Zhou, Jia Wang, (unknown), Feng Yang, Xiaoqing Cai, Qing Liu, Olivier Nosjean, Jean A. Boutin, Pierre Renard, Dehua Yang, Ming‐Wei Wang	12
3	Agomelatine, the first melatonergic antidepressant: discovery, characterization and development 2010 ·Nature Reviews Drug Discovery ·Christian de Bodinat, Béatrice Guardiola‐Lemaître, Elisabeth Mocaër, Pierre Renard, Carmen Muñoz, Mark J. Millan	342
4	Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT1 melatoninergic ligands 2010 ·Bioorganic & Medicinal Chemistry ·Christophe Mésangeau, Basile Pérès, (unknown), Philippe Chavatte, Valérie Audinot, (unknown), Jean A. Boutin, Philippe Delagrange, Caroline Bennejean, Pierre Renard, Daniel H. Caignard, Pascal Berthelot, Saı̈d Yous	23
5	Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands 2008 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Basile Pérès, Jean A. Boutin, Valérie Audinot, Caroline Bennejean, Philippe Delagrange, Daniel H. Caignard, Pierre Renard, Pascal Berthelot, Daniel Lesieur, Saı̈d Yous	24
6	Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production 2004 ·European Journal of Medicinal Chemistry ·Cyril Sarrauste de Menthière, Alain Chavanieu, Gérard Grassy, Stéphane Dalle, Guillermo Salazar, A. Kervran, Bruno Pfeiffer, Pierre Renard, Philippe Delagrange, Dominique Manéchez, (unknown), Alain Ktorza, Bernard Calas	21
7	Melatonin Reduces Body Weight Gain in Sprague Dawley Rats with Diet-Induced Obesity 2003 ·Endocrinology ·Bénédicte Prunet‐Marcassus, (unknown), (unknown), Katie Louche, Philippe Delagrange, Pierre Renard, Louis Casteilla, Luc Pénicaud	234
8	New selective ligands of human cloned melatonin MT1 and MT2 receptors 2003 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Valérie Audinot, François Mailliet, (unknown), Anne Bonnaud, (unknown), (unknown), Sandra Dromaint, Marianne Rodriguez, Nadine Nagel, Jean‐Pierre Galizzi, Benoît Malpaux, Gérald Guillaumet, Daniel Lesieur, François Lefoulon, Pierre Renard, Philippe Delagrange, Jean A. Boutin	216
9	Potential Inhibitors of Angiogenesis. Part II: 3-(Azolylmethylene)-2,3-dihydrobenzo[b]furan-2-ones 2003 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Emmanuelle Braud, Muriel Duflos, Guillaume Le Baut, Pierre Renard, Bruno Pfeiffer, Gordon C. Tucker	2
10	Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands 2003 ·Bioorganic & Medicinal Chemistry ·Saı̈d Yous, (unknown), Emmanuelle Lipka, (unknown), (unknown), Valérie Audinot, Jean A. Boutin, Philippe Delagrange, Caroline Bennejean, Pierre Renard, Daniel Lesieur	30
11	Synthesis of New Aromatic Pyrrolo[2,1- c] [1,4]benzodiazepines and Pyrrolo[1,2- a] thieno[3,2- e] [1,4]diazepines as Anti-tumoral Agents 2002 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Vincent Lisowski, Frédéric Fabis, Alain St. Pierre, Daniel‐Henri Caignard, Pierre Renard, Sylvain Rault	19
12	Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands 2001 ·Bioorganic & Medicinal Chemistry ·Maria Anastassiadou, Saı̈da Danoun, (unknown), G Baziard-Mouysset, M Payard, Daniel‐Henri Caignard, Marie‐Claire Rettori, Pierre Renard	49
13	Cytotoxic activities of novel hexahydroindolizino[8,7-b]indole derivatives prepared by 1,3-dipolar cycloaddition reactions of 3,4-dihydro-β-carboline ylides 2001 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), Christiane Gaspard, Georges H. Werner, Bruno Pfeiffer, Pierre Renard, Stéphane Léonce, Robert H. Dodd	13
14	Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle 2001 ·Bioorganic & Medicinal Chemistry Letters ·Ying Li, Feng Shan, Jinming Wu, (unknown), Jian Ding, (unknown), Weiyi Yang, Ghanem Atassi, Stéphane Léonce, Daniel‐Henri Caignard, Pierre Renard	76
15	PARA-XYLENE PRODUCTION: INTEGRATING MODERN TECHNOLOGICAL SOLUTIONS INTO AN EXISTING COMPLEX 2000 ·(unknown), (unknown), (unknown), Pierre Renard	0
16	A convenient extension of the Wessely–Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro 2000 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Brian Lockhart, Pierre Renard, Martine Largeron	112
17	Synthesis and Cytotoxic Activity of Pyranophenanthridine Analogues of Fagaronine and Acronycine. 1998 ·Chemical and Pharmaceutical Bulletin ·(unknown), (unknown), François Tillequin, Pierre Renard, Stéphane Léonce, Alain St. Pierre, Ghanem Atassi	4
18	Melatonin analogues as agonists and antagonists in the circadian system and other brain areas 1996 ·European Journal of Pharmacology ·Shui‐Wang Ying, Benjamin Rusak, Philippe Delagrange, Elisabeth Mocaër, Pierre Renard, Béatrice Guardiola‐Lemaître	99
19	N-Substituted Oxazolo[5,4-b]pyridin-2(1H)-ones: A New Class of Non-Opiate Antinociceptive Agents 1995 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Bruno Pfeiffer, Pierre Renard, Daniel‐Henri Caignard, (unknown), Gérald Guillaumet	49
20	Synthesis and Structure-Activity Relationships of Novel Naphthalenic and Bioisosteric Related Amidic Derivatives as Melatonin Receptor Ligands 1994 ·Journal of Medicinal Chemistry ·Patrick Depreux, Daniel Lesieur, (unknown), Peter J. Morgan, H.E. Howell, Pierre Renard, Daniel‐Henri Caignard, Bruno Pfeiffer, Philippe Delagrange	125

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact